Making Medical Treatment Decisions for Unrepresented Older Adults

Publication Date: November 30, 2024
Last Updated: December 10, 2024

Recommendations From Making Medical Treatment Decisions for Unrepresented Older Adults

  • The term “unrepresented” should replace the term “unbefriended” when referring to a person who (1) lacks decisional capacity to provide informed consent to a particular medical treatment; (2) has not executed an advance directive that addresses the medical treatment at hand and lacks capacity to do so; and (3) lacks representation from a surrogate decision maker (i.e., family, friend, or legally authorized surrogate).
  • National stakeholders should work together to identify best practices and to create more uniform legal standards regarding unrepresented older adults that could be considered for adoption by all states.
  • States should expand their laws to explicitly allow nontraditional surrogates to serve as representatives for older adults, and clinicians and healthcare institutions should advocate for the inclusion of nontraditional surrogates whenever appropriate.
  • Clinicians, health care organizations, communities, and other stakeholders should work proactively to prevent older adults without potential surrogates from becoming unrepresented.
  • 5. Clinicians, health care organizations, communities, and other stakeholders should develop innovative, efficient, and accessible approaches to promote adequate protections and procedural fairness in decision making for unrepresented older adults.
  • Medical decision making for unrepresented older adults should include adequate safeguards against ad hoc approaches, seek consensus where possible, and ensure procedural fairness.
  • Clinicians should assess medical decision-making capacity in a systematic fashion.
  • Clinicians and healthcare institutions should develop, standardize, and systematize methods to make decisions for unrepresented older adults in urgent, life-threatening situations.
  • Clinicians and healthcare institutions should ensure that patients with long-term incapacity have longitudinal access to a decision-making surrogate who is familiar with the patient's medical condition and specific circumstances.
  • When applying the best interest standard to unrepresented older adults, institutional committees should synthesize all available evidence, and should take steps to guard against perpetuating forms of potential bias in decision making for this highly vulnerable population.

Recommendation Grading

Disclaimer

The information in this patient summary should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.

Overview

Title

Making Medical Treatment Decisions for Unrepresented Older Adults

Authoring Organization

American Geriatrics Society

Publication Month/Year

November 30, 2024

Last Updated Month/Year

December 10, 2024

Document Type

Consensus

Country of Publication

US

Document Objectives

This paper is an official position statement of the American Geriatrics Society (AGS) and updates the 2017 AGS position statement, Making Medical Treatment Decisions for Unbefriended Older Adults. In this updated position statement, the term "unbefriended" is replaced by "unrepresented" as a term that is more value-neutral, more accurately describes the circumstance in which a person without medical decision-making capacity does not have recognized surrogate representation, and better aligns with increasingly preferred terminology as reflected in recent medical literature. We define unrepresented older adults as those who (1) lack decisional capacity to provide informed consent for a particular medical treatment, (2) have not executed an advance directive that addresses the medical treatment at hand and lack capacity to do so, and (3) lack representation from a surrogate decision-maker (i.e., family, friend, or legally authorized surrogate). Making medical decisions on behalf of unrepresented older adults is exceptionally challenging and, given demographic trends, is likely to become increasingly common in the years ahead. The process of arriving at treatment decisions for this population should follow standards of procedural fairness and include capacity assessment, search for potential surrogates, team-based efforts to determine the patient's values and preferences, and steps to guard against bias. Proactive measures are needed to identify older adults at risk for becoming unrepresented. This position statement also calls for national efforts to reduce state-to-state variability in legal approaches for unrepresented patients.

Inclusion Criteria

Male, Female, Older adult

Health Care Settings

Ambulatory, Hospital, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Counseling, Management

Keywords

older adults

Source Citation

Dixon JD, Josyula AV, Javier NM, Zweig Y, Singh M, Kim L, Thothala N, Farrell TW. American Geriatrics Society position statement: Making medical treatment decisions for unrepresented older adults. J Am Geriatr Soc. 2024 Nov 30. doi: 10.1111/jgs.19288. Epub ahead of print. PMID: 39614758.